ARTSaVIT

About

ARTSaVIT is developing a molecular mechanism of apoptosis induced by apoptotic-related tumor suppressors (ARTS). The company's goal is to determine how the binding of ARTS to inhibitors of apoptosis proteins and other apoptotic regulators causes caspase activation and cell death. Thelab currently focuses on the molecular mechanism of ARTS-induced apoptosis, therole of ARTS as a tumor suppressor in a variety of cancer models, and the development ofin-vitro and cell-based assays for the identification and screening of small-molecule ARTS mimetics that will selectively kill cancer cells and serve as anticancer drugs. ARTSaVIT operates within the framework of Merck Ventures Israel BioIncubator.

Facts

Funding rounds (2)

Team (1)

News mentions (1)

1. Jan 4, 2017 — www.globes.co.il: Article